152 related articles for article (PubMed ID: 21237257)
1. Effect of casting solvent on crystallinity of ondansetron in transdermal films.
Pattnaik S; Swain K; Mallick S; Lin Z
Int J Pharm; 2011 Mar; 406(1-2):106-10. PubMed ID: 21237257
[TBL] [Abstract][Full Text] [Related]
2. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
3. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
5. Crystal modification of dipyridamole using different solvents and crystallization conditions.
Adhiyaman R; Basu SK
Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
7. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
Uchino T; Yasuno N; Yanagihara Y; Suzuki H
Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
[TBL] [Abstract][Full Text] [Related]
8. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
Tran TT; Tran PH; Park JB; Lee BJ
Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
[TBL] [Abstract][Full Text] [Related]
9. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
10. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
11. Investigation on solvent casting films of surfactant-encapsulated clusters.
Bu W; Wu L; Hou X; Fan H; Hu C; Zhang X
J Colloid Interface Sci; 2002 Jul; 251(1):120-4. PubMed ID: 16290709
[TBL] [Abstract][Full Text] [Related]
12. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
13. The solid-state characterization of fusidic acid.
Gilchrist SE; Letchford K; Burt HM
Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
[TBL] [Abstract][Full Text] [Related]
14. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
16. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers.
Williams AC; Timmins P; Lu M; Forbes RT
Eur J Pharm Sci; 2005 Nov; 26(3-4):288-94. PubMed ID: 16087323
[TBL] [Abstract][Full Text] [Related]
17. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
Sher P; Ingavle G; Ponrathnam S; Pawar AP
Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
[TBL] [Abstract][Full Text] [Related]
18. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
19. Solvents effects on crystallinity and dissolution of β-artemether
Xu J; Singh V; Yin X; Singh P; Wu L; Xu X; Guo T; Sun L; Gui S; Zhang J
Drug Dev Ind Pharm; 2017 Mar; 43(3):372-378. PubMed ID: 27781497
[TBL] [Abstract][Full Text] [Related]
20. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
